磷酸二酯酶6β抗体
5''-cyclic phosphodiesterase subunit beta; Congenital stationary night blindness 3 autosomal dominant; CSNB 3; CSNB3; CSNBAD2; GMP PDE beta; GMP-PDE beta; PDE 6 beta; PDE 6B; PDE6B; PDE6B_HU
包含氧化还原酶的WW域抗体
D16S432E; FOR; FOR II protein; FRA16D; Fragile 16D oxido reductase; fragile site FRA16D oxidoreductase; HHCMA 56; HHCMA56; PRO0128; putative oxidoreductase; WOX 1; WOX1; WW domain containing oxidoredu
载脂蛋白A1抗体
AI BP; AIBP; ApoA I binding protein; Apolipoprotein A I; Apolipoprotein A 1; Apo AI; ApoA I; APOA1; APOA1/APOC3 fusion gene; Apo A1; Apo-A1; Apolipoprotein A I precursor; Apolipoprotein A I binding pr
氨基糖苷类磷酸结构域蛋白抗体
AGPD1_HUMAN; Agphd1; Aminoglycoside phosphotransferase domain containing; Aminoglycoside phosphotransferase domain-containing protein 1; C630028N24Rik; OTTMUSP00000025874; RGD1308677.
磷酸化原癌基因c-Jun抗体
c-Jun (Phospho-Thr239); c-Jun (phospho T239); p-c-Jun (phospho T239); Transcription factor AP-1; Jun oncogene; JUN; AP 1; AP1; AP-1; Enhancer Binding Protein AP1; Jun Activation Domain Binding Protein
网格蛋白重链抗体
CHC17; Clathrin heavy chain 1; Clathrin heavy chain 2; Clathrin heavy chain; Clathrin heavy chain like 1; Clathrin heavy chain on chromosome 17; Clathrin heavy polypeptide; CLH 17; CLH 22; CLH-17; CLH
PRAM1蛋白抗体
PML RAR; PML RARA regulated adaptor molecule 1; PML RARA target gene encoding an Adaptor Molecule 1; PML-RARA-regulated adapter molecule 1; PRAM 1; PRAM; PRAM-1; PRAM_HUMAN; PRAM1.